Development and validation of the Ascertain Dementia 8 (AD8) Thai version

dc.contributor.authorThaipisuttikul P.
dc.contributor.authorNakawiro D.
dc.contributor.authorKuladee S.
dc.contributor.authorChittaropas P.
dc.contributor.authorSukying C.
dc.contributor.otherMahidol University
dc.date.accessioned2023-06-18T17:41:40Z
dc.date.available2023-06-18T17:41:40Z
dc.date.issued2022-11-01
dc.description.abstractBackground: The Ascertain Dementia 8 (AD8) is a brief informant-based questionnaire which reliably distinguishes patients with neurocognitive disorder (NCD) and normal cognition. Our objective was to translate the AD8 into Thai and test its validity as a potentially useful measure to detect patients with the mild stage of major NCD due to Alzheimer disease (major NCD-AD). Methods: Evaluations of 144 informant–patient dyads were made. Participants were patients who attended the memory clinic at Ramathibodi Hospital and non-patient volunteers. The AD8-Thai version was administered separately from doctor's interviews and neuropsychological assessments. Diagnostic workups included a complete medical history, physical and neurological examinations, neuropsychological testing, the Clinical Dementia Rating Scale-Sum of Boxes (CDR-SOB), Montreal Cognitive Assessment (MoCA), blood tests and brain imaging, preferably with magnetic resonance imaging. All researchers were blinded to the AD8 results. Results: An AD8 score ≥3 had a sensitivity of 95.5%, a specificity of 89.5%, a positive predictive value of 84%, and a negative predictive value of 97.1% for screening major NCD-AD and those with normal cognition. A subgroup analysis with participants aged ≥65 years and with ≥12 years of education revealed comparable ability to the whole group. AD8 scores had a moderate negative relationship with MoCA scores (r = −0.470) and a strong positive relationship with CDR-SOB scores (r = 0.547). The performance of AD8 scores in differentiating mild NCD from normal cognition was not as good as for major NCD-AD. Conclusions: AD8-Thai version is an acceptable screening tool for major NCD-AD. For patients aged 65 years or older, with at least 12 years of education, and with cognitive complaints in memory clinic, an AD8-Thai score of 3 or more would be sufficient to work on major NCD diagnosis. The performance of the AD8-Thai in mild NCD needs further investigation.
dc.identifier.citationPsychogeriatrics Vol.22 No.6 (2022) , 795-801
dc.identifier.doi10.1111/psyg.12884
dc.identifier.eissn14798301
dc.identifier.issn13463500
dc.identifier.pmid36319270
dc.identifier.scopus2-s2.0-85135522091
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/85430
dc.rights.holderSCOPUS
dc.subjectMedicine
dc.titleDevelopment and validation of the Ascertain Dementia 8 (AD8) Thai version
dc.typeArticle
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85135522091&origin=inward
oaire.citation.endPage801
oaire.citation.issue6
oaire.citation.startPage795
oaire.citation.titlePsychogeriatrics
oaire.citation.volume22
oairecerif.author.affiliationRamathibodi Hospital

Files

Collections